Makers Laboratories Ltd
₹153.30
(3.90%)
Sun, 15 Mar 2026, 03:47 pm
Makers Laboratories Ratios
| Particulars | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Price to earnings ratio | 2.19 | 6.37 | 4.55 | 0 | 3.67 | 13.06 | 11.91 | 12.89 | 13.34 | 11.77 | 10.57 | 0 | 0 | 18.03 | 0 | 0 | 10.16 |
| Price to book ratio | 0.43 | 1.26 | 0.77 | 0.51 | 0.40 | 0.34 | 1.14 | 1.13 | 1.45 | 0.98 | 0.62 | 0.33 | 2.17 | 1.51 | 0.83 | 1.05 | 1.08 |
| Price to sales ratio | 0.13 | 0.41 | 0.35 | 0.16 | 0.15 | 0.11 | 0.43 | 0.49 | 0.85 | 0.64 | 0.56 | 0.29 | 1.72 | 0.71 | 0.58 | 0.64 | 0.63 |
| Price to cash flow ratio | 1.35 | 30.71 | 2.89 | 2.28 | 2.45 | 2.27 | 11.06 | 7.04 | 8.94 | 134.05 | 4.56 | 3.72 | 0 | 11.82 | 0 | 0 | 0 |
| Enterprise value | 115.75M | 282.61M | 263.98M | 182.27M | 129.45M | 97.3M | 287.25M | 286.92M | 465.89M | 360.45M | 300.19M | 267.36M | 1.6B | 1.39B | 1.08B | 1.22B | 1.25B |
| Enterprise value to EBITDA ratio | 4.72 | 8.21 | 0 | 18.12 | 3.21 | 4.08 | 6.89 | 6.54 | 8.56 | 7.83 | 11.91 | 8.80 | 19.64 | 7.30 | 32.89 | 152.62 | 15.54 |
| Debt to equity ratio | 0.55 | 0.75 | 0.56 | 0.43 | 0.20 | 0.09 | 0.03 | 0.01 | 0.04 | 0.04 | 0.15 | 0.29 | 0.31 | 0.33 | 0.19 | 0.31 | 0.07 |
| Return on equity % | 0 | 21.55 | 19.99 | -2.84 | 11.58 | 2.63 | 9.90 | 9.05 | 12.25 | 9.17 | 6.24 | -0.29 | -0.67 | 8.76 | -7.38 | -9.47 | 11.22 |
Makers Laboratories Ltd Ratios
The Makers Laboratories Ltd Ratios page provides a complete fundamental analysis of Makers Laboratories Ltd using key valuation, profitability, and financial strength metrics. Investors tracking Makers Laboratories Ltd Ratios closely monitor D/E, EV, EV/EBITDA, P/B, P/CF, P/E, P/S, and ROE% to evaluate the company's financial performance and valuation trends over time.
Makers Laboratories Ltd (NSE: , BSE: 506919) is currently trading at ₹153.30, with a market capitalization of ₹870.6M. As a major player in the Health technology sector and Pharmaceuticals: major industry, Makers Laboratories Ltd remains a key stock for fundamental analysis using Makers Laboratories Ltd Ratios.
Makers Laboratories Ltd Ratios: Valuation Overview
Price to Earnings Ratio (P/E)
The Makers Laboratories Ltd P/E ratio currently stands at 10.16, making it one of the most tracked metrics in Makers Laboratories Ltd Ratios.
Historically, the Makers Laboratories Ltd P/E ratio has shown strong fluctuations:
- 2024: 10.16
- 2023: 0
- 2022: 0
- 2021: 18.03
- 2020: 0
The rising Makers Laboratories Ltd P/E ratio indicates increasing investor confidence and premium valuation.
Price to Book Ratio (P/B)
The Makers Laboratories Ltd P/B ratio reflects how the market values the company's net assets. Current P/B ratio is 1.08.
Historical P/B trend:
- 2024: 1.08
- 2023: 1.05
- 2022: 0.83
- 2021: 1.51
Makers Laboratories Ltd shows reasonable valuation compared to its asset base.
Price to Sales Ratio (P/S)
The Makers Laboratories Ltd P/S ratio currently stands at 0.63, an important part of Makers Laboratories Ltd Ratios for revenue valuation.
Historical P/S ratio:
- 2024: 0.63
- 2023: 0.64
- 2022: 0.58
- 2021: 0.71
A stable or declining Makers Laboratories Ltd P/S ratio indicates cautious market sentiment.
Makers Laboratories Ltd Price to Cash Flow Ratio (P/CF)
The Makers Laboratories Ltd Price to Cash Flow Ratio is a key valuation metric that shows how much investors pay for each unit of cash flow. Current P/CF ratio is 0.
Historical Makers Laboratories Ltd Price to Cash Flow Ratio:
- 2024: 0
- 2023: 0
- 2022: 0
- 2021: 11.82
- 2020: 0
The declining Makers Laboratories Ltd Price to Cash Flow Ratio suggests improving cash flow strength.
Makers Laboratories Ltd Enterprise Value Ratios
Enterprise Value (EV)
The Makers Laboratories Ltd EV currently stands at ₹1.25B, representing the total company valuation including debt.
Historical EV trend:
- 2024: 1.25B
- 2023: 1.22B
- 2022: 1.08B
- 2021: 1.39B
Makers Laboratories Ltd enterprise value shows long-term growth, reflecting expansion and market confidence.
EV/EBITDA Ratio
The Makers Laboratories Ltd EV/EBITDA ratio is currently 15.54, a key metric in Makers Laboratories Ltd Ratios to assess valuation relative to earnings.
Historical EV/EBITDA:
- 2024: 15.54
- 2023: 152.62
- 2022: 32.89
- 2021: 7.30
Stable Makers Laboratories Ltd EV/EBITDA indicates balanced valuation.
Makers Laboratories Ltd Financial Strength Ratios
Debt to Equity Ratio (D/E)
The Makers Laboratories Ltd D/E ratio is currently 0.07, reflecting leverage and financial stability.
Historical D/E:
- 2024: 0.07
- 2023: 0.31
- 2022: 0.19
- 2021: 0.33
Makers Laboratories Ltd maintains a strong balance sheet with low debt levels.
Return on Equity (ROE %)
The Makers Laboratories Ltd ROE currently stands at 11.22%, showing profitability and capital efficiency.
Historical ROE:
- 2024: 11.22
- 2023: -9.47
- 2022: -7.38
- 2021: 8.76
Makers Laboratories Ltd maintains stable profitability levels.
Makers Laboratories Ltd Ratios Analysis Summary
The Makers Laboratories Ltd Ratios page provides a comprehensive view of the company's valuation and financial performance. Key metrics such as P/E, P/B, P/S, P/CF, EV, EV/EBITDA, D/E, and ROE help investors understand whether Makers Laboratories Ltd stock is undervalued, fairly valued, or overvalued.
Tracking Makers Laboratories Ltd Ratios regularly helps investors make informed decisions based on valuation trends, financial stability, and long-term growth potential.
Open Your Free Demat Account Now!
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800